Enveric Biosciences, Inc. ENVB
1.42 USD 0.00 (+0.28%)
At closeNov 9, 2026, 4:54 AM EST
1.40 -0.02 -1.69%
Pre-market · Nov 9, 4:54 AM ET
1.38 Day range 1.46
1.17 52-week range 13.25
- YTD
- -60.77%
- 1 year
- -76.42%
News
benzinga.com Enveric Biosciences Reports Favorable Brain Activity Data for Lead Psychiatric Drug Candidate Enveric Biosciences reports positive preclinical qEEG results for EB-003, confirming brain activity and favorable safety in mice.
businesswire.com Enveric Biosciences Reports Differentiated Brain Activity Profile for EB-003 in Preclinical qEEG Study CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Tempest Therapeutics (NASDAQ:TPST) stock rose 8.9% to $0.57 during Wednesday's after-market session. The market value of their outstanding shares is at $10.1 million. Tenax Therapeutics…
benzinga.com Enveric Biosciences Reports Favorable Preclinical Results for Non-Hallucinogenic Psychiatric Candidate Enveric Biosciences posts positive preclinical data for EB-003, showing favorable absorption and safety for psychiatric therapies.